• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增殖性糖尿病视网膜病变中主要周边病变与视网膜微血管及玻璃体积血风险的关联

Association of predominant peripheral lesions with retinal microvasculature and risk of vitreous hemorrhage in proliferative diabetic retinopathy.

作者信息

Gan Jenny, Ding Xinyi, Ploumi Ioanna, Romano Francesco, Overbey Katherine M, Garcia Mauricio D, Garg Itika, Vingopoulos Filippos, Stettler Isabella, Finn Matthew J, Razavi Peyman, Rodriguez Jocelyn M, Bennett Cade F, Patel Nimesh A, Kim Leo A, Husain Deeba, Vavvas Demetrios G, Miller John B

机构信息

Harvard Retinal Imaging Lab, Boston, MA, USA.

Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, Boston, MA, 02114, USA.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2025 Aug 19. doi: 10.1007/s00417-025-06864-z.

DOI:10.1007/s00417-025-06864-z
PMID:40828403
Abstract

PURPOSE

This study examines the association between predominant peripheral lesions (PPL) and retinal microvasculature with the short-term risk of vitreous hemorrhage (VH) in eyes with proliferative diabetic retinopathy (PDR).

METHODS

A total of 111 PDR eyes from 84 patients with the same day Ultra-widefield Color Fundus Photography (Optos) and Swept-source Optical Coherence Tomography Angiograms (PLEX Elite 9000). UWF images were graded by 2 independent graders for PPL, defined as over 50% of diabetic lesions localized in the extended field compared to its respective ETDRS field. Only one field with PPL was required for the eye to be graded as having PPL. Ischemia index (ISI) and other OCTA metrics were calculated on FIJI and ARI network software. Retinal microvasculature alterations in 6 × 6-mm and 12 × 12-mm angiograms were compared between eyes with and without PPL using Generalized Estimating Eq. 101 eyes from 75 patients followed for at least 3 months were included in the prospective part of this study. Additionally, patient history of complications and treatments were reviewed, and a multilevel Cox mixed-effect regression was applied to analyze PPL as predictors for the development of VH.

RESULTS

PPL were identified in 36 out of 111 eyes (32.4%). OCTA parameters didn't show significant differences in groups with or without PPL. Over a period of 16.4 ± 11.0 months, VH occurred in 23 eyes, 14 with a history of VH and 9 without. A significant association was found between PPL presence and new VH occurrence (p = 0.028) but not for recurrent VH (P > 0.05). The extent of PPL was a significant predictor for the new VH, after adjustments for age, DM duration and prior anti-vascular endothelial growth factor (anti-VEGF) and panretinal photocoagulation (PRP) treatment (HR = 1.92, p = 0.03, 95% CI [1.06-3.50]).

CONCLUSION

Center and posterior OCTA metrics are comparable in eyes with or without PPL, but PPL is associated with VH development. Advancements in UWF imaging technologies may lead to the development of a new DR grading scheme to predict VH risk in patients with PDR.

摘要

目的

本研究探讨增殖性糖尿病视网膜病变(PDR)患者中主要周边病变(PPL)与视网膜微血管系统与玻璃体出血(VH)短期风险之间的关联。

方法

对84例患者的111只PDR眼进行同一天的超广角彩色眼底照相(Optos)和扫频光学相干断层扫描血管造影(PLEX Elite 9000)。UWF图像由2名独立分级人员对PPL进行分级,PPL定义为糖尿病病变在扩展视野中所占比例超过其各自ETDRS视野的50%。一只眼只要有一个视野存在PPL就被分级为有PPL。在FIJI和ARI网络软件上计算缺血指数(ISI)和其他OCTA指标。使用广义估计方程比较有和没有PPL的眼睛在6×6mm和12×12mm血管造影中的视网膜微血管改变。本研究的前瞻性部分纳入了75例患者的101只眼,随访至少3个月。此外,回顾了患者的并发症和治疗史,并应用多级Cox混合效应回归分析PPL作为VH发生的预测因素。

结果

111只眼中有36只(32.4%)发现有PPL。OCTA参数在有或没有PPL的组中没有显示出显著差异。在16.4±11.0个月的时间里,23只眼发生了VH,14只眼有VH病史,9只眼没有。发现PPL的存在与新的VH发生之间存在显著关联(p = 0.028),但与复发性VH无关(P>0.05)。在调整年龄、糖尿病病程以及既往抗血管内皮生长因子(抗VEGF)和全视网膜光凝(PRP)治疗后,PPL的程度是新VH的显著预测因素(HR = 1.92,p = 0.03,95%CI [1.06 - 3.50])。

结论

有或没有PPL的眼睛中,中央和后部OCTA指标具有可比性,但PPL与VH的发生有关。UWF成像技术的进步可能会导致开发一种新的DR分级方案,以预测PDR患者的VH风险。

相似文献

1
Association of predominant peripheral lesions with retinal microvasculature and risk of vitreous hemorrhage in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中主要周边病变与视网膜微血管及玻璃体积血风险的关联
Graefes Arch Clin Exp Ophthalmol. 2025 Aug 19. doi: 10.1007/s00417-025-06864-z.
2
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较:一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
3
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病视网膜病变的比较:系统评价与经济分析
Health Technol Assess. 2025 May 7:1-16. doi: 10.3310/KRWP1264.
4
Clinical and imaging characteristics associated with foveal neovascularization in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中与黄斑中心凹新生血管相关的临床和影像学特征。
Graefes Arch Clin Exp Ophthalmol. 2025 Mar;263(3):679-687. doi: 10.1007/s00417-024-06660-1. Epub 2024 Nov 15.
5
Different lasers and techniques for proliferative diabetic retinopathy.用于增殖性糖尿病视网膜病变的不同激光和技术。
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012314. doi: 10.1002/14651858.CD012314.pub2.
6
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病性视网膜病变的比较:一项系统评价和荟萃分析。
Health Technol Assess. 2024 Dec 11:1-71. doi: 10.3310/PCGV5709.
7
Anti-VEGF Injections vs. Panretinal Photocoagulation Laser Therapy for Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis.抗血管内皮生长因子注射与全视网膜光凝激光治疗增殖性糖尿病视网膜病变的系统评价和荟萃分析
Ophthalmol Retina. 2025 Feb;9(2):105-121. doi: 10.1016/j.oret.2024.08.004. Epub 2024 Aug 14.
8
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.抗血管内皮生长因子预防增殖性糖尿病视网膜病变玻璃体切除术后玻璃体腔出血
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3.
9
Ultra-Widefield and Early Treatment Diabetic Retinopathy Study 7-Field Grading of Diabetic Retinopathy.《超广角和糖尿病视网膜病变研究》7 字段糖尿病视网膜病变分级。
JAMA Ophthalmol. 2024 Sep 1;142(9):856-863. doi: 10.1001/jamaophthalmol.2024.2890.
10
Laser therapy for retinopathy in sickle cell disease.镰状细胞病视网膜病变的激光治疗
Cochrane Database Syst Rev. 2015 Oct 9;2015(10):CD010790. doi: 10.1002/14651858.CD010790.pub2.

本文引用的文献

1
Association of Diabetic Lesions and Retinal Nonperfusion Using Widefield Multimodal Imaging.广角多模态成像与糖尿病性病变及视网膜无灌注的相关性研究。
Ophthalmol Retina. 2023 Dec;7(12):1042-1050. doi: 10.1016/j.oret.2023.07.020. Epub 2023 Jul 28.
2
Semi-automated algorithm using directional filter for the precise quantification of non-perfusion area on widefield swept-source optical coherence tomography angiograms.使用方向滤波器的半自动算法用于在宽视野扫频源光学相干断层扫描血管造影上精确量化无灌注区。
Quant Imaging Med Surg. 2023 Jun 1;13(6):3688-3702. doi: 10.21037/qims-21-1175. Epub 2023 Mar 20.
3
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time.
超广角成像中主要为周边病变与糖尿病视网膜病变随时间恶化风险的相关性。
JAMA Ophthalmol. 2022 Oct 1;140(10):946-954. doi: 10.1001/jamaophthalmol.2022.3131.
4
Multimodal imaging analysis for the impact of retinal peripheral lesions on central neurovascular structure and retinal function in type 2 diabetes with diabetic retinopathy.多模态影像分析 2 型糖尿病伴糖尿病视网膜病变患者视网膜周边病变对中心神经血管结构和视网膜功能的影响
Br J Ophthalmol. 2023 Oct;107(10):1496-1501. doi: 10.1136/bjo-2022-321297. Epub 2022 Jun 30.
5
American Society of Retina Specialists Clinical Practice Guidelines on the Management of Nonproliferative and Proliferative Diabetic Retinopathy without Diabetic Macular Edema.美国视网膜专家协会关于无糖尿病性黄斑水肿的非增殖性和增殖性糖尿病视网膜病变管理的临床实践指南。
J Vitreoretin Dis. 2020 Mar 1;4(2):125-135. doi: 10.1177/2474126419893829. Epub 2020 Jan 6.
6
Widefield Swept-Source OCT Angiography Metrics Associated with the Development of Diabetic Vitreous Hemorrhage: A Prospective Study.与糖尿病性玻璃体积血发生相关的超广角扫频源光学相干断层扫描血管造影指标:一项前瞻性研究。
Ophthalmology. 2021 Sep;128(9):1312-1324. doi: 10.1016/j.ophtha.2021.02.020. Epub 2021 Feb 26.
7
Efficacy of intravitreal AFlibercept injection For Improvement of retinal Nonperfusion In diabeTic retinopathY (AFFINITY study).玻璃体内注射阿柏西普改善糖尿病视网膜病变视网膜无灌注的疗效(AFFINITY研究)
BMJ Open Diabetes Res Care. 2020 Oct;8(1). doi: 10.1136/bmjdrc-2020-001616.
8
Screening for diabetic retinopathy: new perspectives and challenges.糖尿病视网膜病变筛查:新视角与新挑战。
Lancet Diabetes Endocrinol. 2020 Apr;8(4):337-347. doi: 10.1016/S2213-8587(19)30411-5. Epub 2020 Feb 27.
9
Distribution of peripheral lesions identified by mydriatic ultra-wide field fundus imaging in diabetic retinopathy.散瞳超广角眼底成像检查发现的糖尿病视网膜病变周边病变的分布。
Graefes Arch Clin Exp Ophthalmol. 2020 Apr;258(4):725-733. doi: 10.1007/s00417-020-04607-w. Epub 2020 Jan 27.
10
ETDRS Grading of Diabetic Retinopathy: Still the Gold Standard?糖尿病视网膜病变的 ETDRS 分级:仍是金标准吗?
Ophthalmic Res. 2019;62(4):190-195. doi: 10.1159/000501372. Epub 2019 Aug 27.